Evidence map›Paper›PMID 40861583›Full record

ArticleCureus2025

BCL2-Rearrangment-Negative CD23+ Follicle Center Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Rare Case of Biclonal Composite Lymphoma.

Hira Qadir, Ejas Palathingal Bava, Juan Gomez-Gelvez, Wei Liu, Kedar Inamdar, Elizabeth Wey, John Carey, Yulei Shen, Philip Kuriakose, Sharmila Ghosh

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hira QadirPathology and Laboratory Medicine, Henry Ford Health System, Detroit, USA.
Ejas Palathingal BavaPathology and Laboratory Medicine, Henry Ford Health System, Detroit, USA.
Juan Gomez-GelvezPathology and Laboratory Medicine, Henry Ford Health System, Detroit, USA.
Wei LiuPathology and Laboratory Medicine, Henry Ford Health System, Detroit, USA.
Kedar InamdarPathology and Laboratory Medicine, Henry Ford Health System, Detroit, USA.
Elizabeth WeyPathology and Laboratory Medicine, Henry Ford Health System, Detroit, USA.
John CareyPathology and Laboratory Medicine, Henry Ford Health System, Detroit, USA.
Yulei ShenPathology and Laboratory Medicine, Henry Ford Health System, Detroit, USA.
Philip KuriakoseHematology and Medical Oncology, Henry Ford Health System, Detroit, USA.
Sharmila GhoshPathology and Laboratory Medicine, Henry Ford Health System, Detroit, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Composite lymphomas are rare and diagnostically complex, comprising two or more distinct lymphoma subtypes within the same anatomical site and often requiring a comprehensive diagnostic approach. Due to their rarity and varied presentations, further research is needed to better understand their pathogenesis, clonal relationships, and optimal management strategies. This case report highlights an unusual presentation of composite lymphoma involving the coexistence of BCL2-R-negative, CD23-positive follicle center lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

Indexed as

bcl2-r–negativecd23-positive follicle center lymphomaclonally distinct b-cell lymphomascomposite lymphomasmall lymphocytic lymphoma

Identifiers

PMID40861583
PMCPMC12375284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.